Get started
Author

Pauline Robbe

Observed names: P Robbe, Robbe P, Robbe, P., Robbe, Pauline
Observed institutions: John Radcliffe Hospital, National Institute for Health and Care Research, University of Oxford, RIKEN, Oxford University Hospitals NHS Trust, RIKEN Center for Integrative Medical Sciences
ORCID: 0000-0002-0691-1126
Observed ORCID: 0000-0002-0691-1126
OpenAlex ID: A5010275907
SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage
2013 · Ruth Clifford, Tania Louis, et al. · Blood · 230
PDF
Clinical whole-genome sequencing from routine formalin-fixed, paraffin-embedded specimens: pilot study for the 100,000 Genomes Project
2018 · Pauline Robbe, Niko Popitsch, et al. · Genetics in Medicine · 178
PDF
Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLL
2015 · Romain Guièze, Pauline Robbe, et al. · Blood · 101
PDF
Genomic and transcriptomic correlates of Richter transformation in chronic lymphocytic leukemia
2020 · Jenny Klintman, Niamh Appleby, et al. · Blood · 90
PDF
Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia
2016 · H Parker, M J J Rose-Zerilli, et al. · Leukemia · 83
PDF
Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features
2022 · Pauline Robbe, Kate E. Ridout, et al. · Nature Genetics · 76
PDF
Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHVmut and IgHVunmut subgroups
2017 · A Burns, R Alsolami, et al. · Leukemia · 70
PDF
Targeted deep sequencing reveals clinically relevant subclonal IgHV rearrangements in chronic lymphocytic leukemia
2016 · B Stamatopoulos, A Timbs, et al. · Leukemia · 62
Clinical significance of TP53, BIRC3, ATM and MAPK-ERK genes in chronic lymphocytic leukaemia: data from the randomised UK LRF CLL4 trial
2020 · Stuart J. Blakemore, Ruth Clifford, et al. · Leukemia · 48
PDF
The Light Chain IgLV3-21 Defines a New Poor Prognostic Subgroup in Chronic Lymphocytic Leukemia: Results of a Multicenter Study
2018 · Basile Stamatopoulos, Thomas Smith, et al. · Clinical Cancer Research · 46
PDF
Large-scale analysis of whole genome sequencing data from formalin-fixed paraffin-embedded cancer specimens demonstrates preservation of clinical utility
2024 · Shadi Basyuni, Laura Heskin, et al. · Nature Communications · 38
PDF
Clinical significance of DNA methylation in chronic lymphocytic leukemia patients: results from 3 UK clinical trials
2019 · Tomasz K. Wojdacz, Harindra E. Amarasinghe, et al. · Blood Advances · 34
PDF
Comparative analysis of somatic variant calling on matched FF and FFPE WGS samples
2020 · Louise de Schaetzen van Brienen, Maarten Larmuseau, et al. · BMC Medical Genomics · 30
PDF
Clinical‐grade validation of whole genome sequencing reveals robust detection of low‐frequency variants and copy number alterations in CLL
2018 · Jenny Klintman, Katerina Barmpouti, et al. · British Journal of Haematology · 21
PDF
Genome-wide association study identifies risk loci for progressive chronic lymphocytic leukemia
2021 · Wei-Yu Lin, Sarah E. Fordham, et al. · Nature Communications · 17
PDF
Using Genomic Information to Guide Ibrutinib Treatment Decisions in Chronic Lymphocytic Leukaemia: A Cost-Effectiveness Analysis
2017 · James Buchanan, Sarah Wordsworth, et al. · PharmacoEconomics · 13
PDF
Erratum: Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHVmut and IgHVunmut subgroups
2017 · A Burns, R Alsolami, et al. · Leukemia · 10
PDF
Genomic Stratification of Hematological Malignancies
2023 · Pauline Robbe, Anna Schuh · HemaSphere · 6
Development and Evaluation of the Clinical Utility of a Next Generation Sequencing (NGS) Tool for Myeloid Disorders
2014 · Angela Hamblin, Adam Burns, et al. · Blood · 6
Enabling whole genome sequencing analysis from FFPE specimens in clinical oncology
2025 · Dylan Domenico, Gunes Gundem, et al. · Nature Communications · 3
PDF
Long‐term follow‐up of 415 patients with chronic lymphocytic leukemia treated with fludarabine and cyclophosphamide‐based chemoimmunotherapy in the frontline ADMIRE and ARCTIC trials: A comprehensive assessment of prognostic factors
2022 · David John Allsup, Zoe Craig, et al. · American Journal of Hematology · 3
PDF
Protocol for direct cDNA cap analysis of gene expression for paired-end patterned flow cell sequencing
2025 · Diane Delobel, Hiromi Nishiyori-Sueki, et al. · STAR Protocols · 2
The diagnostic chronic lymphocytic leukaemia genome by nanopore sequencing
2019 · Adam Burns, Daniella DiSalvo-Williams, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2
PDF
The contribution of gene mutations to long-term clinical outcomes: data from the randomised UK LRF CLL4 trial
2017 · Stuart J. Blakemore, Ruth Clifford, et al. · ePrints Soton (University of Southampton) · 2
Towards Response Prediction Using Integrated Genomics in Chronic Lymphocytic Leukaemia: Results on 250 First-Line FCR Treated Patients from UK Clinical Trials
2014 · Ruth M Clifford, Pauline Robbe, et al. · Blood · 2
Works count: 59
Citation count: 1,185
H-index: 15
I10-index: 17
Year
Topic
Type